Najat Khan
Chief R&D Officer and Chief Commercial Officer
Other
CEO
Board Member
Earnings-call appearances
-
Recursion Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-06
Recursion Pharmaceuticals, Inc. (RXRX)
-
Recursion Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-25
Recursion Pharmaceuticals, Inc. (RXRX)
-
Recursion Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-05
Recursion Pharmaceuticals, Inc. (RXRX)
-
Recursion Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-05
Recursion Pharmaceuticals, Inc. (RXRX)
-
Recursion Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-05
Recursion Pharmaceuticals, Inc. (RXRX)
-
Recursion Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-08
Recursion Pharmaceuticals, Inc. (RXRX)